is vertigo a side effect of tirzepatide Lightheadedness on Tirzepatide: Causes, Management, and Prevention Head Rushes and Tirzepatide :

Neumiller: For SGLT2 inhibitors, it is important to educate people with type 1 diabetes about situations and factors that can increase their risk for experiencing DKA, such as acute illness, engaging in strenuous exercise, excessive alcohol intake, missing insulin doses, dramatic decreases in carbohydrate intake and insulin pump failure

The FDA advises against using compounded versions unless approved medications are not available or you cannot tolerate the approved medication

Charles, Missouri, for physician-supervised Semaglutide treatment for weight loss.

Dose-Response Patterns Phase 1/2 trials tested CJC-1295 with DAC at single doses ranging from 30-250 mcg/kg (PMID 16352683)